Montpensier Arbervel
Fiche investisseur | Builders Republic
À propos
Montpensier Arbevel is a major independent French asset management firm resulting from the strategic merger of Montpensier Finance and Financière Arbevel in January 2025. Combining entrepreneurial DNA with institutional scale, the firm manages over €5 billion across public and private markets. While widely recognized for its active management in listed equities (SME/ETI) and convertible bonds, Montpensier Arbevel operates a distinct "Private Markets" division inherited primarily from Arbevel's expertise. This division focuses on Private Equity and Private Debt, supporting innovative growth companies—particularly in the healthcare and deeptech sectors—through cross-over strategies and direct unlisted investments.
Informations clés
- Type
- IM / Cross-over Fund
- Stades
- Series B,Growth
- Secteurs
- Healthcare,Biotech
- Siège
- France
- Bureaux
- Paris
- Focus géographique
- France
- Lead / Follow
- Can lead and follow
- Fondé en
- 2004
Track record
- Investissements totaux: 13
Investissements notables en France
Uromems, Germitec, Keranova, NG Biotech, CorWave